Introduction
Magnetic resonance imaging (MRI) has been used for the detection of liver tumors. 1, 2 However, the MRI method has its own drawback, because of wide biological variations and considerable overlap of T 1 and T 2 values of tumors and normal livers. Also, the similarity between the signals of hepatic tumors and adjacent normal liver tissue made them hard to discern. 3 Use of iron oxide in the form of superparamagnetic ferrite crystals has recently been reported to improve the detection of hepatic metastasis with MRI. [4] [5] [6] Contrast agents consist of iron oxide nanoparticles magnetite (Fe 3 O 4 ) or other ferrite, which are insoluble in water. Superparamagnetic agents are highly effective in MRI. Their relaxivities, R 1 and R 2, are higher than those of gadolinium chelates currently available. 7 Few methods are available to quantify iron oxide nanoparticles in biological samples, using inductively coupled plasma (ICP) atomic emission spectrometry. So the objective of this work is to develop a method to validate an ICP method to quantify Fe concentration in rat plasma for the calculation of pharmacokinetic parameters in rats.
Experimental Section
Materials and Reagents. Dextran kD40 were supplied by Sigma Chemicals Ltd. and used as received. Water was doubly distilled and pure nitrogen gas was bubbled through it for more than 2 h just before used to remove dissolved oxygen. Nitrogen was purified of traces of carbon dioxide and oxygen by passing it through a basic pyrogallol solution. All other chemicals used were of analytical grade and were used as received.
For the validation of the method, rat plasma samples were obtained from Wistar rats from pooled heparinized blood samples and stored at -20 o C before use. The plasma was used for preparation of calibration and for quality control.
ICP operating conditions and wavelengths of emission lines examined. π$P Sample Processing. Samples were directly nebulized; each determination was performed in replicate (n = 5).
Preparation of Magnetite Nanoparticles Coated with Dextran (MD
The matrix effect was investigated using water, 25% water diluted rat plasma samples and pure rat plasma.
Instrument Calibration. Two calibration curves were performed in the matrices: the first one at the concentrations of 0, 0.125, 0.250, 0.375, 0.500, 0.625 and 0.750 µg⋅mL −1 of Fe; and the second one at concentrations of 0, 0.250, 0.500, 0.750, 1.000 and 1.250, 1.500 µg⋅mL −1 of Fe. Data Analysis. Analyses were performed on an ICP atomic emission spectrometer 4300DV (ICP Optima Emission Spectrometer Per Kin-Elmer USA). The concentration of iron in the blank blood samples (C b ) was determined and then the total concentration of iron after i.v. administration (C t ) was determined. The real concentration (C r ) was computed as follows: C r = (C b − C t ) × 25; where 25 is the dilution ratio.
Finally, pharmacokinetic analysis was performed using the Topfit 2.0 (GmbH. Shering AG, Go decke AG, Germany).
Precision and Accuracy. Inter-day and intra-day reproducibility of the assay were assessed by performing replicate analyses of quality control samples in studied matrices [water and 25% (w/w) diluted plasma], containing iron at the concentrations of 0.05, 0.50, 5.00 µg⋅mL −1
. The procedure was repeated on different days of the same spiked standards to determine inter-day repeatability. Intra-day repeatability was determined by treating spiked samples in replicate the same day. The recovery test was also performed. The results are reported in Table 1 .
Effect of Dilution. To study the application of the described method to samples with concentrations higher than the last calibration point, spiked samples were prepared in blank plasma (0.05-5.00 µg⋅mL −1 ) and diluted with water to bring the concentration within the range of standard curve. Each analysis was performed in replicate and the concentration was determined using a calibration curve in 25% (w/w) diluted plasma. The concentration was compared with the nominal ones.
The direct injection of pure rat plasma was not plausible due to the risk of obstructing the nebulizer. Several unknown samples were diluted [25% (w/w)] in water before assay, and this dilution was validated using QC samples at 0.05, 0.50, 5.00 µg⋅mL −1 in pure plasma. The results are shown in Table 2 . Determination of the Limits of Quantification and Detection. The limits of quantification were defined as the lowest drug concentrations that can be determined with an accuracy between 100 ± 20% and a relative standard deviation below or equal to 20% on a day-to-day basis. To determine the analytical error in the determination of the limits of quantification, spiked samples were used.
The limits of detection were defined as the sample concentration resulting in a mean corrected intensity of three times the noise level.
Pharmacokinetic Study. The inductively coupled plasma emission spectrometric method was used to quantify Fe concentration in rat plasma for pharmacokinetic study after i.v. administration of 0.5 mg⋅kg −1 body weight of MD. Wistar rats weighing 180-200 g (7 weeks old) were housed in an environmentally controlled room with a 12 h light/dark cycle. Diet and tap water were provided ad libitum, MD dissolved in H 2 O (11.2 mg⋅mL Intensity of Fe varied linearly with concentration over the range used. Peak intensity at analysis 238.204 nm for the MD was plotted against the concentration of the MD added. The determination coefficients (R 2 ) for calibration curves were equal to or better than 0.999 for water and 0.9978 for 25% diluted plasma. Line range was 0.05-5.00 µg⋅mL −1 . Precision and Accuracy. Recovery was 101.0, 88.0, and 89.4%, respectively, and RSD was 5.6. Therefore, the accuracy was within an acceptable range. Results of the intra-day and inter-day precisions are presented in Table 1 .
Results and Discussion
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Effect of Dilution. The dilution had no influence on the performance of the method, which could then be used for concentrations up to 5.00 µg⋅mL −1 ( Table 2 ). The limits of Quantification and Detection. The limit of quantification and detection under the described conditions was 0.1 µg⋅mL −1 and 0.05 µg⋅mL , respectively, for water and for 25% in diluted plasma. At these concentrations, the relative standard deviation around the mean value did not exceed 15.0%.
In general, the detection limit of Fe in ICP-MS (inductively coupled plasma mass spectrometer) was much lower than that of ICP-OES (inductively coupled plasma optical emission spectroscopy).
Pharmacokinetic Study. The ICP method was used to analyze plasma samples containing MD obtained after i.v. administration to rats (3.53 mg⋅kg
−1
). Concentration vs. time profile (Fig. 1) was constructed for up to 12 h for the analyses (n = 3). We conducted the pharmacokinetic analyses via Topfit 2.0 (GmbH. Shering AG, Gdecke AG, Germany). The statistical results based on SD, AIC and R 2 show that a two-compartment model is the best choice to fit the data. The pharmacokinetic parameters of the MD two-compartment model are given in Table 3 . The figure of V c (volume of drug in the central compartment) (0.021 ± 0.003) and V 3 (volume of drug in the peripheral compartment) (0.506 ± 0.022) show that MD in vivo aggregated in the peripheral compartment (tissue) and not in the central compartment (blood, extra cellular fluid and highly perfuse tissue). The data of t 1/2(α) (central compartment; 0.01 ± 0.002) and t 1/2(β) (peripheral compartment; 5.38 ± 0.125 h) imply that MD eliminated faster from the central compartment than from the peripheral compartment. C max was 166.67 ± 20.599 (mean ± SD) mg⋅L −1 in rats at 0.133 h. The total plasma clearance was 1.187 ± 0.032 (mean ± SD) mL⋅min . The advanced pharmacokinetic analysis will be performed in the future.
In this study, a method to quantity Fe in plasma, using plasma emission spectrometry, is described. Assay performance was assessed both on the basis of the statistical , n = 4, mean ± SD). characteristics of individual calibration lines and from the results of quality control samples. The matrix effect was studied using water, diluted plasma and plasma itself. Inductively coupled plasma emission spectrometry was used to detect concentration of magnetite nanoparticles in rats for the first time. The quantitative analysis ability of the inductively coupled plasma emission spectrometry shows its high performance in determining the concentration of biological samples.
